70144-1Cannabinoids [Presence] in Urine by Screen method >20 ng/mLActive
Part Description
LP16058-7 Cannabinoids
The group of drugs called cannabinoids includes both the cannabinoid chemicals found in the cannabis plant as well as synthetic and pharmaceutical cannabinoids. The cannabinoids in cannabis include tetrahydrocannabinol (THC), cannabidiol (CBD), and cannabinol (CBN). THC is responsible for the psychoactive effects of cannabis and binds to the CB1 and CB2 cannabinoid receptors. CBD does not have psychoactive effects but rather has a variety of therapeutic properties including anticonvulsant, analgesic, anti-anxiety, and antiemetic. The THC to CBD ratio determines the physiologic effects of the drug. A high THC/CBD ratio results in euphoric and anxiolytic effects, while a low THC/CBD ratio results in sedative effects. Both natural and synthetic cannabinoid compounds are used for therapeutic purposes. Synthetic cannabinoids, like THC, act on the CB1 and CB2 receptors. Adverse reactions, including psychosis, confusion, agitation, tachycardia, myocardial infarction, seizures, and fatal overdoses, are more common with synthetic cannabinoids compared to cannabis. [PMID:30275754]
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Cannabinoids
- Property
- PrThr
- Time
- Pt
- System
- Urine
- Scale
- Ord
- Method
- Screen>20 ng/mL
Additional Names
- Short Name
- Cannabinoids Ur Ql Scn>20 ng/mL
- Display Name
- Cannabinoids Screen method >20 ng/mL Ql (U)
- Consumer Name Alpha
- Cannabinoids, Urine
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.40
- Last Updated
- Version 2.73
- Change Reason
- The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
- Order vs. Observation
- Both
- Common US Lab Results Rank
- 9868
Reference Information
Type | Source | Reference |
---|---|---|
Package Insert | Ortho Clinical Diagnostics | Example package insert. This LOINC code is not constrained to this specific product. VITROS Chemistry Products THC Reagent |
Member of these Groups
LG37608-3 | Cannabinoids| |
LG14043-0 | Cannabinoids| |
Language Variants Get Info
- zh-CNChinese (China)
- 大麻类:
存在情况或阈值: 时间点: 尿液: 序数型: 筛查试验 > 20 纳克/毫升 - nl-NLDutch (Netherlands)
- cannabinoïden:
aanwezigheid: moment: urine: ordinaal: screening > 20 ng/mL - fr-BEFrench (Belgium)
- Cannabinoïdes:
PrThr: Temps ponctuel: Urine: Ordinal: Dépistage>20 ug/L - fr-CAFrench (Canada)
- Cannabinoïdes:
Présence-Seuil: Temps ponctuel: Urine: Ordinal: Dépistage>20 ug/L - fr-FRFrench (France)
- Cannabinoïdes:
Présence/Seuil: Ponctuel: Urine: Qualitatif: Recherche>20µg/L - it-ITItalian (Italy)
- Cannabinoidi:
PrThr: Pt: Urine: Ord: Screening>20 ng/mL - pt-BRPortuguese (Brazil)
- Cannabinóides:
Limiar: Pt: Urina: Ord: Triagem>20 ng/mL - es-MXSpanish (Mexico)
- Cannabinoides:
Presencia o umbral: Punto temporal: Orina: Ordinal: Pantalla> 20 ng / mL - es-ESSpanish (Spain)
- Cannabinoides:
PrThr: Punto temporal: Orina: Ord: Screening >20 ng/ml - tr-TRTurkish (Turkey)
- Kannabinoidler:
MevcEşik: Zmlı: İdrar: Srl: Tarama>20 ng/mL
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=70144-1
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright